Almac buys BioClin in cross-border expansion
Northern Ireland pharmaceutical giant Almac Group has snapped up a contract laboratory here as part of continued expansion.
The firm is thought to have spent a multimillion pound sum on buying BioClin Laboratories in Athlone.
It's the latest expansion for Almac Group in the Republic after it bought Arran Chemical Company, also in Athlone, two years ago. The BioClin deal adds 35 people to Almac's workforce of around 5,000.
Last year, it announced the opening of a new site at the IDA Business Park in Dundalk as part of its Brexit planning.
But a spokeswoman said the latest deal had "nothing to do with Brexit" and was part of "global expansion".
"BioClin is located around 10km from Arran so the existing facilities and skills are there."
She said the premises would be within the 'analytic services' section of Almac. BioClin carries out analytical services and data reporting to support drug development in Garrycastle.
"Adding BioClin's highly complementary analytical capacity and technical expertise to our existing capabilities, along with investment in nearby Arran and the opening of our new lab in Craigavon, means that we can broaden our service offerings and address our global clients' growing demands for a high quality, integrated, efficient service," said Almac Sciences MD Stephen Barr.